{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28186109", "DateCompleted": {"Year": "2018", "Month": "10", "Day": "22"}, "DateRevised": {"Year": "2023", "Month": "06", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "02", "Day": "10"}], "Language": ["eng"], "ELocationID": ["42021", "10.1038/srep42021"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "7", "PubDate": {"Year": "2017", "Month": "Feb", "Day": "10"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?", "Pagination": {"StartPage": "42021", "MedlinePgn": "42021"}, "Abstract": {"AbstractText": ["Neurotoxicity is a major side effect of platinum derivatives both during and after treatment. In the absence of effective pharmacological compounds, the opportunity to identify safe adjuvant treatments among medicinal plants seems appropriate. Astragali radix is an adaptogenic herbal product recently analyzed in platinum-treated cancer patients. With the aim of evaluating the anti-neuropathic profile of Astragali radix, a previously characterized aqueous (Aqu) and two hydroalcoholic (20%HA and 50%HA) extracts were tested in a rat model of oxaliplatin-induced neuropathy. Repeated administrations significantly reduced oxaliplatin-dependent hypersensitivity with 50%HA, the most effective, fully preventing mechanical and thermal hypersensitivity. Ex vivo, 50%HA reduced morphometric and molecular alterations induced by oxaliplatin in peripheral nerve and dorsal-root-ganglia. In the spinal cord and in brain areas, 50%HA significantly decreased activation of microglia and astrocytes. Furthermore, 50%HA prevented the nephro- and hepato-toxicity induced by the anticancer drug. The protective effect of 50%HA did not alter oxaliplatin-induced apoptosis in colon tumors of Pirc rats, an Apc-driven model of colon carcinogenesis. The hydroalcoholic extract (50%HA) of Astragali radix relieves pain and promotes the rescue mechanisms that protect nervous tissue from the damages triggering chronic pain. A safe profile strongly suggests the usefulness of this natural product in oxaliplatin-induced neuropathy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Di Cesare Mannelli", "ForeName": "Lorenzo", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Experimental and Clinical Medicine - DECM - Section of Anatomy and Histology, University of Florence, Florence, Italy."}], "LastName": "Pacini", "ForeName": "Alessandra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Micheli", "ForeName": "Laura", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Femia", "ForeName": "Angelo Pietro", "Initials": "AP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Maresca", "ForeName": "Mario", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Zanardelli", "ForeName": "Matteo", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Vannacci", "ForeName": "Alfredo", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Gallo", "ForeName": "Eugenia", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Florence, Florence, Italy."}], "LastName": "Bilia", "ForeName": "Anna Rita", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Caderni", "ForeName": "Giovanna", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Firenzuoli", "ForeName": "Fabio", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Mugelli", "ForeName": "Alessandro", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dept. of Neuroscience, Psychology, Drug Research and Children's Health - NEUROFARBA - Pharmacology and Toxicology Section, Florence, Italy."}], "LastName": "Ghelardini", "ForeName": "Carla", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Retracted Publication"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Organoplatinum Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "04ZR38536J", "NameOfSubstance": "Oxaliplatin"}], "CommentsCorrectionsList": [{"RefSource": "Sci Rep. 2023 Jun 20;13(1):9979. doi: 10.1038/s41598-023-37011-5", "PMID": "37339997"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Astragalus Plant"}, {"QualifierName": ["pathology"], "DescriptorName": "Brain"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["pathology"], "DescriptorName": "Ganglia, Spinal"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Neurotoxicity Syndromes"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Organoplatinum Compounds"}, {"QualifierName": [], "DescriptorName": "Oxaliplatin"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Roots"}, {"QualifierName": ["pathology"], "DescriptorName": "Pudendal Nerve"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["pathology"], "DescriptorName": "Spinal Cord"}], "CoiStatement": "This research was funded by the Italian Ministry of Instruction, University and Research (MIUR) and by the University of Florence. L.D.C.M., M.Z., A.R.B., F.F., A.V., E.G., A.M. and C.G. are listed as inventors on a patent about the pain reliever effect of Astragalus extract. The patent was sold and the authors do not currently have any commercial interest. All other authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Avan A. et al.. Platinum-induced neurotoxicity and preventive strategies: Past, present, and future. Oncologist. 20, 411\u2013432 (2015).", "ArticleIdList": ["PMC4391771", "25765877"]}, {"Citation": "Saif M. W. & Reardon J. Management of oxaliplatin-induced peripheral neuropathy. Ther. Clin. Risk Manag. 1, 249\u2013258 (2005).", "ArticleIdList": ["PMC1661634", "18360567"]}, {"Citation": "De Gramont A. et al.. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol. 18, 2938\u20132947 (2000).", "ArticleIdList": ["10944126"]}, {"Citation": "Souglakos J. et al.. Triplet combination with irinotecan plus oxaliplatin plus continuous infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial. J. Clin. Oncol. 20, 2651\u20132657 (2002).", "ArticleIdList": ["12039926"]}, {"Citation": "Kannarkat G., Lasher E. E. & Schiff D. Neurologic complications of chemotherapy agents. Curr. Op. Neurol. 20, 719\u2013725 (2007).", "ArticleIdList": ["17992096"]}, {"Citation": "Fallon M. T. Neuropathic pain in cancer. Br. J. Anaesth. 111, 105\u201311 (2013).", "ArticleIdList": ["23794652"]}, {"Citation": "Mols F., Beijers T., Vreugdenhil G. & van de Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 22, 2261\u20132269 (2014).", "ArticleIdList": ["24789421"]}, {"Citation": "Hershman D. L. et al.. American Society of Clinical Oncology. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J. Clin. Oncol. 32, 1941\u20131967 (2014).", "ArticleIdList": ["24733808"]}, {"Citation": "Majithia N. et al.. National Cancer Institute-supported chemotherapy induced peripheral neuropathy trials: Outcomes and lessons. Support Care Cancer. 24, 1439\u20131447 (2016).", "ArticleIdList": ["PMC5078987", "26686859"]}, {"Citation": "Smith E. M. et al.. Alliance for Clinical Trials in Oncology. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAM. 309, 1359\u20131367 (2013).", "ArticleIdList": ["PMC3912515", "23549581"]}, {"Citation": "Beijers A. J., Mols F. & Vreugdenhil G. A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration. Support Care Cancer. 22, 1999\u20132007 (2014).", "ArticleIdList": ["24728618"]}, {"Citation": "Efferth T. & Koch E. Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Targets 12, 122\u201332 (2011).", "ArticleIdList": ["20735354"]}, {"Citation": "Di Cesare Mannelli L. et al.. In Vitro Evidence for the Use of Astragali Radix Extracts as Adjuvant against Oxaliplatin-Induced Neurotoxicity. Planta Med. 81, 1045\u201355 (2015).", "ArticleIdList": ["26039263"]}, {"Citation": "Sinclair S. Chinese herbs: a clinical review of Astragalus, Ligusticum, and Schizandrae. Altern. Med. Rev. 3, 338\u201344 (1998).", "ArticleIdList": ["9802911"]}, {"Citation": "Fu J. et al.. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother. Res. 28, 1275\u20131283 (2014).", "ArticleIdList": ["25087616"]}, {"Citation": "Chen M., May B. H., Zhou I. W., Xue C. C. & Zhang A. L. FOLFOX 4 combined with herbal medicine for advanced colorectal cancer: a systematic review. Phytother. Res. 28, 976\u2013991 (2014).", "ArticleIdList": ["24343974"]}, {"Citation": "Chen M., May B. H., Zhou I. W., Xue C. C. & Zhang A. L. Meta-analysis of Oxaliplatin-based chemotherapy combined with traditional medicines for colorectal cancer: Contributions of specific plants to tumor response. Integr. Cancer Ther. 15, 40\u201359 (2016).", "ArticleIdList": ["PMC5736077", "26254190"]}, {"Citation": "Deng B., Jia L. & Cheng Z. Radix Astragali-Based Chinese Herbal Medicine for Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Evid. Based Complement. Alternat. Med. 2016, 2421876 (2016).", "ArticleIdList": ["PMC5067479", "27795728"]}, {"Citation": "Di Cesare Mannelli L. et al.. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain. J. Pain. 14, 1585\u20131600 (2013).", "ArticleIdList": ["24135431"]}, {"Citation": "Di Cesare Mannelli L. et al.. Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity. PLoS One. 10, e0128080 (2015).", "ArticleIdList": ["PMC4454493", "26039098"]}, {"Citation": "Di Cesare Mannelli L. et al.. Glial role in oxaliplatin-induced neuropathic pain. Exp. Neurol. 261, 22\u201333 (2014).", "ArticleIdList": ["24967684"]}, {"Citation": "Tsujino H. et al.. Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury. Mol. Cell. Neurosci. 15, 170\u2013182 (2000).", "ArticleIdList": ["10673325"]}, {"Citation": "Moisset X. et al.. Functional brain imaging of trigeminal neuralgia. Eur. J. Pain. 15, 124\u2013131 (2011).", "ArticleIdList": ["20609605"]}, {"Citation": "Boland E. G. et al.. Central pain processing in chronic chemotherapy-induced peripheral neuropathy: a functional magnetic resonance imaging study. PLoS One. 9, e96474 (2014).", "ArticleIdList": ["PMC4018287", "24821182"]}, {"Citation": "Koornstra J. J., de Jong S., Hollema H., de Vries E. G. & Kleibeuker J. H. Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature. Crit. Rev. Oncol. Hematol. 45, 37\u201353 (2003).", "ArticleIdList": ["12482571"]}, {"Citation": "Holmes J. et al.. Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model. Toxicol. Sci. 46, 342\u2013351 (1998).", "ArticleIdList": ["10048138"]}, {"Citation": "Carlton S. M. et al.. Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury. Pain. 147, 265\u2013276 (2009).", "ArticleIdList": ["PMC2787843", "19853381"]}, {"Citation": "Petzold A. Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss. J. Neurol. Sci. 233, 183\u2013198 (2005).", "ArticleIdList": ["15896809"]}, {"Citation": "von Hehn C. A., Baron R. & Woolf C. J. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron. 73, 638\u2013652 (2012).", "ArticleIdList": ["PMC3319438", "22365541"]}, {"Citation": "Jacobs S. S. et al.. Extracellular fluid concentrations of cisplatin, carboplatin and oxaliplatin in brain, muscle and blood measured using microdialysis in nonhuman primates. Cancer Chemother. Pharmacol. 65, 817\u2013824 (2010).", "ArticleIdList": ["PMC6936607", "19662415"]}, {"Citation": "Melzack R. From the gate to the neuromatrix. Pain. Suppl 6, S121\u2013S126 (1999).", "ArticleIdList": ["10491980"]}, {"Citation": "Seifert F. & Maih\u00f6fner C. Functional and structural imaging of pain-induced neuroplasticity. Curr. Opin. in Anaesthesiol. 24, 515\u2013523 (2011).", "ArticleIdList": ["21822136"]}, {"Citation": "Milligan E. D. & Watkins L. R. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 10, 23\u201336 (2009).", "ArticleIdList": ["PMC2752436", "19096368"]}, {"Citation": "He Y. et al.. Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels. PLoS One. 8, e76495 (2013).", "ArticleIdList": ["PMC3790693", "24124567"]}, {"Citation": "Qi L. W. et al.. Quality evaluation of Radix Astragali through a simultaneous determination of six major active isoflavonoids and four main saponins by high-performance liquid chromatography coupled with diode array and evaporative light scattering detectors. J. Chromatogr. A. 1134, 162\u2013169 (2006).", "ArticleIdList": ["16982063"]}, {"Citation": "Jin M., Zhao K., Huang Q. & Shang P. Structural features and biological activities of the polysaccharides from Astragalus membranaceus. Int. J. Biol. Macromol. 64, 257\u2013266 (2014).", "ArticleIdList": ["24325861"]}, {"Citation": "Xu X. et al.. In vitro synergistic antioxidant activity and identification of antioxidant components from Astragalus membranaceus and Paeonia lactiflora. PLoS One. 9, e96780 (2014).", "ArticleIdList": ["PMC4016014", "24816851"]}, {"Citation": "Di Cesare Mannelli L., Zanardelli M., Failli P. & Ghelardini C. Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J. Pain. 13, 276\u2013284 (2012).", "ArticleIdList": ["22325298"]}, {"Citation": "Khodagholi F. & Tusi S. K. Stabilization of Nrf2 by tBHQ prevents LPS-induced apoptosis in differentiated PC12 cells. Mol. Cell. Biochem. 354, 97\u2013112 (2011).", "ArticleIdList": ["21461609"]}, {"Citation": "Wang R., Paul V. J. & Luesch H. Seaweed extracts and unsaturated fatty acid constituents from the green alga Ulva lactuca as activators of the cytoprotective Nrf2-ARE pathway. Free Radic. Biol. Med. 57, 141\u2013153 (2013).", "ArticleIdList": ["PMC3663146", "23291594"]}, {"Citation": "Tian Z. et al.. Neuroprotective effects of formononetin against NMDA-induced apoptosis in cortical neurons. Phytother. Res. 27, 1770\u20131775 (2013).", "ArticleIdList": ["23362211"]}, {"Citation": "Zhang X. & Chen J. The mechanism of astragaloside IV promoting sciatic nerve regeneration. Neural. Regen. Res. 8, 2256\u20132265 (2013).", "ArticleIdList": ["PMC4146037", "25206535"]}, {"Citation": "Chien C. F., Wu Y. T. & Tsai T. H. Biological analysis of herbal medicines used for the treatment of liver diseases. Biomed. Chromatogr. 25, 21\u201338 (2011).", "ArticleIdList": ["21204110"]}, {"Citation": "Femia A. P., Luceri C., Soares P. V., Lodovici M. & Caderni G. Multiple mucin depleted foci, high proliferation and low apoptotic response in the onset of colon carcinogenesis of the PIRC rat, mutated in Apc. Int. J. Cancer. 136, E488\u201395 (2015).", "ArticleIdList": ["25257656"]}, {"Citation": "McCulloch M. et al.. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J. Clin. Oncol. 24, 419\u2013430 (2006).", "ArticleIdList": ["16421421"]}, {"Citation": "Zhang A. et al.. Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO. J. Cancer Res. Clin. Oncol. 140, 1883\u20131890 (2014).", "ArticleIdList": ["24980548"]}, {"Citation": "Tin M. M., Cho C. H., Chan K., James A. E. & Ko J. K. S. Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogenesis. 28, 1347\u20131355 (2007).", "ArticleIdList": ["17148504"]}, {"Citation": "Cui R. et al.. Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother. Pharmacol. 51, 75\u201380 (2003).", "ArticleIdList": ["12497209"]}, {"Citation": "Zong A., Cao H. & Wang F. Anticancer polysaccharides from natural resources: a review of recent research. Carbohydr. Polym. 90, 1395\u20131410 (2012).", "ArticleIdList": ["22944395"]}, {"Citation": "Portenoy R. K. Treatment of cancer pain. Lancet. 377, 2236\u20132247 (2011).", "ArticleIdList": ["21704873"]}, {"Citation": "McGrath J. C. & Lilley E. Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br. J. Pharmacol. 172, 3189\u20133193 (2015).", "ArticleIdList": ["PMC4500358", "25964986"]}, {"Citation": "Cavaletti G. et al.. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur. J. Cancer. 37, 2457\u20132463 (2001).", "ArticleIdList": ["11720843"]}, {"Citation": "Zanardelli M., Micheli L., Cinci L., Ghelardini C. & Di Cesare Mannelli L. Oxaliplatin neurotoxicity involves peroxisome alterations. PPAR\u03b3 agonism as preventive pharmacological approach. Plos One. 10(6), e0128080 (2015).", "ArticleIdList": ["PMC4103888", "25036594"]}, {"Citation": "Femia A. P. et al.. Sustained proliferation and resistance to apoptosis after a cytotoxic insult are early alterations in rat colon carcinogenesis. Int. J. Cancer. 131, 529\u201336 (2012).", "ArticleIdList": ["21976248"]}]}], "History": [{"Year": "2016", "Month": "6", "Day": "6"}, {"Year": "2017", "Month": "1", "Day": "5"}, {"Year": "2017", "Month": "2", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["28186109", "PMC5301199", "10.1038/srep42021", "srep42021"]}}]}